MTIM
Marathon Trading Investment Management Portfolio holdings
AUM
$167M
This Quarter Return
+4.22%
1 Year Return
+7.67%
3 Year Return
+19.9%
5 Year Return
+20.83%
10 Year Return
+48.77%
AUM
$252M
AUM Growth
-$266M
(-51%)
Cap. Flow
-$335M
Cap. Flow
% of AUM
-132.52%
Top 10 Holdings %
Top 10 Hldgs %
63.67%
Holding
320
New
109
Increased
29
Reduced
43
Closed
73
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$19.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$10.5M |
| 3 |
ProShares Bitcoin Strategy ETF
BITO
|
$9.69M |
| 4 |
Amazon
AMZN
|
$6.18M |
| 5 |
Rivian
RIVN
|
$3.61M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$142M |
| 2 |
NVIDIA
NVDA
|
$98M |
| 3 |
Salesforce
CRM
|
$36.5M |
| 4 |
SPDR Gold Trust
GLD
|
$25.9M |
| 5 |
Home Depot
HD
|
$17.4M |
Sector Composition
| 1 | Financials | 37.02% |
| 2 | Technology | 12.44% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Healthcare | 7.65% |
| 5 | Communication Services | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Dave Inc
DAVE
$2.76B
| $531K | 0.04% |
+14,300
| New | +$531K |
|
|
FPF
52
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.16B
| $524K | 0.04% |
29,250
-750
| -3% | -$13.4K |
|
53
C4 Therapeutics
CCCC
$182M
| $523K | 0.04% |
+64,000
| New | +$523K |
|
54
NET Power
NPWR
$176M
| $521K | 0.04% |
+45,701
| New | +$521K |
|
55
Talkspace
TALK
$444M
| $519K | 0.04% |
+145,300
| New | +$519K |
|
56
Financial Select Sector SPDR Fund
XLF
$53.6B
| $515K | 0.04% |
12,230
-1,847
| -13% | -$77.8K |
|
57
Blend Labs
BLND
$887M
| $514K | 0.04% |
158,100
+125,600
| +386% | +$408K |
|
58
Teladoc Health
TDOC
$1.37B
| $513K | 0.04% |
+34,000
| New | +$513K |
|
59
The RealReal
REAL
$954M
| $512K | 0.04% |
+131,000
| New | +$512K |
|
60
BlackRock Health Sciences Trust II
BMEZ
$1.46B
| $511K | 0.04% |
31,200
-3,800
| -11% | -$62.3K |
|
61
Absci
ABSI
$356M
| $504K | 0.04% |
+88,700
| New | +$504K |
|
62
BlackRock Capital Allocation Term Trust
BCAT
$1.57B
| $500K | 0.04% |
30,000
| – | – |
|
63
Invivyd
IVVD
$218M
| $497K | 0.04% |
+111,900
| New | +$497K |
|
64
Solid Biosciences
SLDB
$448M
| $497K | 0.04% |
+37,300
| New | +$497K |
|
65
The Honest Company
HNST
$441M
| $492K | 0.04% |
+121,600
| New | +$492K |
|
66
National CineMedia
NCMI
$419M
| $487K | 0.04% |
+94,500
| New | +$487K |
|
67
Black Diamond Therapeutics
BDTX
$164M
| $479K | 0.04% |
+94,400
| New | +$479K |
|
68
Akebia Therapeutics
AKBA
$827M
| $476K | 0.04% |
+260,001
| New | +$476K |
|
|
XYZ
69
Block, Inc.
XYZ
$46.2B
| $475K | 0.04% |
5,611
-15,398
| -73% | -$1.3M |
|
70
Micron Technology
MU
$133B
| $466K | 0.04% |
3,954
-16,544
| -81% | -$1.95M |
|
71
American Superconductor
AMSC
$2.2B
| $465K | 0.04% |
+34,400
| New | +$465K |
|
72
Telos
TLS
$470M
| $465K | 0.04% |
+111,700
| New | +$465K |
|
73
AMC Entertainment Holdings
AMC
$1.39B
| $459K | 0.04% |
123,300
-32,580
| -21% | -$121K |
|
74
Groupon
GRPN
$990M
| $458K | 0.04% |
34,343
-8,657
| -20% | -$115K |
|
75
Esperion Therapeutics
ESPR
$490M
| $457K | 0.03% |
170,500
+149,500
| +712% | +$401K |
|